x

Posted 02 March, 2023

cbdMD, Inc. appointed new CEO

CEO Change detected for ticker NYSE:YCBD in a 8-K filed on 02 March, 2023.


  On March 1, 2023, T. Ronan Kennedy agreed to serve as the Company's Interim Chief Executive Officer and Principal Executive Officer and resigned as Chief Operating Officer of the Company in connection thereto.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of cbdMD, Inc.
Health Care/Life Sciences • Pharmaceuticals
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.
Market Cap
$2.12M
View Company Details
cbdMD, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On February 26, 2023, Kevin MacDermott notified cbdMD, Inc. (the "Company") he was resigning as Principal Executive Officer and President of the Company, effective February26, 2023. Mr. MacDermott did not resign as a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

 

On March 1, 2023, T. Ronan Kennedy agreed to serve as the Company's Interim Chief Executive Officer and Principal Executive Officer and resigned as Chief Operating Officer of the Company in connection thereto.